PMCA4 inhibition does not affect cardiac remodelling following myocardial infarction, but may reduce susceptibility to arrhythmia

Ischaemic heart disease is the world’s leading cause of mortality. Survival rates from acute myocardial infarction (MI) have improved in recent years; however, this has led to an increase in the prevalence of heart failure (HF) due to chronic remodelling of the infarcted myocardium, for which treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Stafford, Nicholas, Zi, Min, Baudoin, Florence, Mohamed, Tamer M. A., Prehar, Sukhpal, De Giorgio, Daria, Cartwright, Elizabeth J., Latini, Roberto, Neyses, Ludwig, Oceandy, Delvac
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7810749/
https://www.ncbi.nlm.nih.gov/pubmed/33452399
http://dx.doi.org/10.1038/s41598-021-81170-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7810749/
https://www.ncbi.nlm.nih.gov/pubmed/33452399
http://dx.doi.org/10.1038/s41598-021-81170-2

Ejemplares similares